This all makes sense piecewise, but it doesn't make sense on the whole
I won't blame the company for trying to recoup the costs of developing the drug. At the same time, their profit on this medicine shouldn't make the treatment prohibitive
At the same time part of these costs no doubt come from the rarity of the disease. It's "easy" to run a study for something that a lot of people has, but at the point you have trouble even finding people for a double-blind study this gets tricky (it might be that a control group makes no sense here)
Something like a tax advantage for working on such drugs (and more streamlined testing) might be a better solution than the current situations
It’s not about recouping the costs unfortunately. That’s an industry talking point.
For a brief overview of just how messed up the system has become in the US (where quite a few of the drugs come from) check out this Rogan clip. You don’t have to like Rogan; his guest is amazing.
This guy is hawking supplements, IV hydration, and "stem cell therapy for general health and longevity," among other things, on his personal website. A website that has an entire section dedicated to JRE links. Getting some strong 'Dr Oz but for JoeBros' vibes.
Can't wait to see what other fun new things creep into my youtube suggestions after watching this...
I won't blame the company for trying to recoup the costs of developing the drug. At the same time, their profit on this medicine shouldn't make the treatment prohibitive
At the same time part of these costs no doubt come from the rarity of the disease. It's "easy" to run a study for something that a lot of people has, but at the point you have trouble even finding people for a double-blind study this gets tricky (it might be that a control group makes no sense here)
Something like a tax advantage for working on such drugs (and more streamlined testing) might be a better solution than the current situations